These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1708877)

  • 21. Esmolol attenuates cardiovascular responses to extubation.
    Dyson A; Isaac PA; Pennant JH; Giesecke AH; Lipton JM
    Anesth Analg; 1990 Dec; 71(6):675-8. PubMed ID: 1978612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility.
    Moreno R; Waxman S; Rowe K; Verrier RL
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):722-7. PubMed ID: 11117371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ventricular depolarization gradient: effects of exercise, pacing rate, epinephrine, and intrinsic heart rate control on the right ventricular evoked response.
    Callaghan F; Vollmann W; Livingston A; Boveja B; Abels D
    Pacing Clin Electrophysiol; 1989 Jul; 12(7 Pt 1):1115-30. PubMed ID: 2476749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
    Reilly CS; Wood M; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia.
    Oxorn D; Knox JW; Hill J
    Can J Anaesth; 1990 Mar; 37(2):206-9. PubMed ID: 1968784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation.
    Menigaux C; Guignard B; Adam F; Sessler DI; Joly V; Chauvin M
    Br J Anaesth; 2002 Dec; 89(6):857-62. PubMed ID: 12453930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrillatory effect of esmolol alone and in combination with lidocaine.
    Tisdale JE; Sun H; Zhao H; Fan CD; Colucci RD; Kluger J; Chow MS
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):376-82. PubMed ID: 8907799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology and pharmacokinetics of esmolol.
    Reynolds RD; Gorczynski RJ; Quon CY
    J Clin Pharmacol; 1986 Mar; 26(S1):A3-A14. PubMed ID: 2870084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
    Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
    Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulatory responses during electroconvulsive therapy. The comparative effects of placebo, esmolol and nitroglycerin.
    O'Flaherty D; Husain MM; Moore M; Wolff TR; Sills S; Giesecke AH
    Anaesthesia; 1992 Jul; 47(7):563-7. PubMed ID: 1352662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esmolol and left ventricular function in the awake dog.
    Jacobs JR; Maier GW; Rankin JS; Reves JG
    Anesthesiology; 1988 Mar; 68(3):373-8. PubMed ID: 2894187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of esmolol on cerebral blood flow, cerebral vasoreactivity, and cognitive performance: a functional magnetic resonance imaging study.
    Heinke W; Zysset S; Hund-Georgiadis M; Olthoff D; von Cramon DY
    Anesthesiology; 2005 Jan; 102(1):41-50. PubMed ID: 15618785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternally administered esmolol decreases fetal as well as maternal heart rate.
    Larson CP; Shuer LM; Cohen SE
    J Clin Anesth; 1990; 2(6):427-9. PubMed ID: 1980197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta adrenergic stimulation and blockade in cirrhosis: effects on azygos vein blood flow and portal hemodynamics.
    Weinshel EH; Altszuler HM; Raicht RF; Sedlis SP
    Am J Med Sci; 1994 Jun; 307(6):396-400. PubMed ID: 7911005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
    Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography.
    Weissman NJ; Levangie MW; Newell JB; Guerrero JL; Weyman AE; Picard MH
    Am Heart J; 1995 Aug; 130(2):248-53. PubMed ID: 7631603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
    Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
    J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.